Skip to main content
Log in

Seven cases of Pompe disease from Greece

  • Original Article
  • Published:
Journal of Inherited Metabolic Disease

Summary

We present seven cases of Pompe disease (McKusick 232300; glycogen storage disease type II; acid maltase deficiency) from Greece. The onset of symptoms varied from early childhood to late adulthood, and the patients had quite variable duration of disease. All but one of them had muscle weakness and all had mildly to highly elevated serum creatine kinase. The diagnosis in all cases was confirmed by the finding of acid α-glucosidase (EC 3.2.1.3/20) deficiency in cultured skin fibroblasts. Thirteen mutant alleles were identified and nine different pathogenic mutations were encountered. Four were new: c.2071_2072insAGCCG leads to frameshift and total loss of function; c.1856G > A (p.Ser619Asn) leads to 90–95% loss of function; and the splice-site mutations c.1552−3C > G and c.2331+4A > G reduce the number of correct splicing events by more than 90%. The splice-site mutation c.-32-13T > G (IVS1-13T > G) was encountered four times and seems equally common among Greek and other caucasians. The other mutations: c.925G > A (p.Gly309Arg), c.[307T > G; 271G > A] (p.Cys103Gly; Asp91Asn), c.271del and c.1655T > C (p.Leu552Pro) have been reported earlier. Our study highlights the heterogeneity of Pompe disease in Greece and provides tools for diagnosis and carrier detection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CK:

creatine kinase

ECL:

enhanced chemoluminescence

PCR:

polymerase chain reaction

RT-PCR:

reverse transcription polymerase chain reaction

SDS-PAGE:

sodium dodecyl sulphate–polyacrylamide gel electrophoresis

References

  • Ausems MG, Lochman P, van Diggelen OP, Ploos van Amstel HK, Reuser AJ, Wokke JH (1999) A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 52: 851–853.

    PubMed  CAS  Google Scholar 

  • Bodamer O, Haas D, Hermans M, Reuser A, Hoffmann G (2002) l-Alanine supplementation in late infantile glycogen storage disease type II. Pediatr Neurol 27: 145.

    Article  PubMed  Google Scholar 

  • Boerkoel CF, Exelbert R, Nicastri C, et al (1995) Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 56: 887–897.

    PubMed  CAS  Google Scholar 

  • Chen Y-T (2001) Glycogen storage disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1521–1551.

    Google Scholar 

  • Clavero S, Perez B, Rincon A, Ugarte M, Desviat LR (2004) Qualitative and quantitative analysis of the effect of splicing mutations in propionic acidemia underlying non-severe phenotypes. Hum Genet 115: 239–247.

    Article  PubMed  CAS  Google Scholar 

  • Hermans MMP, van Leenen D, Kroos MA, Reuser AJJ (1997) Mutation detection in glycogen storage-disease type II by RT-PCR and automated sequencing. Biochem Biophys Res Commun 241: 414–418.

    Article  PubMed  CAS  Google Scholar 

  • Hermans MMP, Kroos MA, Smeitink JAM, van der Ploeg AT, Kleijer WJ, Reuser AJJ (1998) Glycogen storage disease type II: genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry. Hum Mutat 11: 209–215.

    Article  PubMed  CAS  Google Scholar 

  • Hermans MM, van Leenen D, Kroos MA, et al (2004) Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype–phenotype correlation in glycogen storage disease type II. Hum Mutat 23: 47–56.

    Article  PubMed  CAS  Google Scholar 

  • Hirschhorn R, Huie ML (1999) Frequency of mutations for glycogen storage disease type II in different populations: the delta525T and deltaexon 18 mutations are not generally “common” in white populations [letter; comment]. J Med Genet 36: 85–86.

    PubMed  CAS  Google Scholar 

  • Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II (GSDII). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Voglstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3389–3420.

    Google Scholar 

  • Huie ML, Chen AS, Tsujino S, et al (1994) Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T->G) mutation in a majority of patients and a novel IVS10 (+1GT->CT) mutation. Hum Mol Genet 3: 2231–2236.

    PubMed  CAS  Google Scholar 

  • Kroos MA, van Leenen D, Verbiest J, Reuser AJ, Hermans MM (1998) Glycogen storage disease type II: identification of a dinucleotide deletion and a common missense mutation in the lysosomal alpha-glucosidase gene. Clin Genet 53: 379–382.

    Article  PubMed  CAS  Google Scholar 

  • Michelakakis H, Mavridou I, Hermans M, Laskari H, Kourkouli M, Reuser A (2000) [Glycogen storage disease type II (Pompe's disease): new mutation in a Greek infant]. Paediatriki 63: 421–426.

    Google Scholar 

  • Pipo JR, Feng JH, Yamamoto T, et al (2003) New GAA mutations in Japanese patients with GSDII (Pompe disease). Pediatr Neurol 29: 284–287.

    Article  PubMed  Google Scholar 

  • Raben N, Nichols RC, Martiniuk F, Plotz PH (1996) A model of mRNA splicing in adult lysosomal storage disease (glycogenosis type II). Hum Mol Genet 5: 995–1000.

    Article  PubMed  CAS  Google Scholar 

  • Reuser AJJ, Koster JF, Hoogeveen A, Galjaard H (1978) Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am J Hum Genet 30: 132–143.

    PubMed  CAS  Google Scholar 

  • Reuser AJJ, Kroos MA, Hermans MMP, et al (1995) Glycogenosis type II (acid maltase deficiency). Muscle Nerve 3: S61–S69.

    Article  PubMed  CAS  Google Scholar 

  • Swallow DM, Corney G, Harris H, Hirschhorn R (1975) Acid α-glucosidase: a new polymorphism in man demonstrable by ‘affinity’ electrophoresis. Ann Hum Genet 1975: 391–406.

    Google Scholar 

  • Swallow DM, Kroos M, Van der Ploeg AT, et al (1989) An investigation of the properties and possible clinical significance of the lysosomal α-glucosidase GAA*2 allele. Ann Hum Genet 53: 177–184.

    PubMed  CAS  Google Scholar 

  • Teraoka SN, Telatar M, Becker-Catania S, et al (1999) Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet 64: 1617–1631.

    Article  PubMed  CAS  Google Scholar 

  • Vorgerd M, Burwinkel B, Reichmann H, Malin JP, Kilimann MW (1998) Adult-onset glycogen storage disease type II: phenotypic and allelic heterogeneity in German patients. Neurogenetics 1: 205–211.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Reuser.

Additional information

Communicating editor: René Santer

Competing interests: None declared

http://www.pompecenter.nl/ http://www.fruitfly.org/seq tools/splice.html http://www.cbs.dtu.dk/services/NetGene2/ http://www.genet.sickkids.on.ca/~ali/splicesitefinder.html http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id = 232300

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kroos, M., Manta, P., Mavridou, I. et al. Seven cases of Pompe disease from Greece. J Inherit Metab Dis 29, 556–563 (2006). https://doi.org/10.1007/s10545-006-0280-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-006-0280-5

Keywords

Navigation